cd 349 has been researched along with dihydropyridines in 22 studies
| Studies (cd 349) | Trials (cd 349) | Recent Studies (post-2010) (cd 349) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 23 | 0 | 0 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 13 (59.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisa, H; Satoh, S; Takahashi, T | 1 |
| Miyata, N; Otomo, S; Tsuchida, K; Yamaura, H | 1 |
| Hisa, H; Satoh, S; Suzuki-Kusaba, M; Takahara, A | 1 |
| Miyata, N; Otomo, S; Tsuchida, K | 1 |
| Aihara, H; Kaneko, K; Tsuchida, K | 1 |
| Kamata, K; Kasuya, Y; Miyata, N; Nishiyama, H | 2 |
| Aihara, H; Muramatsu, M; Otomo, S; Tanaka, M | 1 |
| Kaneko, K; Miyata, N; Otomo, S; Tanaka, M; Tsuchida, K | 1 |
| Fukuuchi, Y; Gotoh, F; Isozumi, K; Izumi, Y | 1 |
| Aihara, H; Muramatsu, M; Tanaka, M | 3 |
| Kimura, Y; Nomura, M; Satoh, S; Yoshida, M | 1 |
| Hidaka, H; Matsushima, S; Saitoh, M; Tanaka, T; Watanabe, M | 1 |
| Aihara, H; Fujita-Tominaga, A; Ishii, Y; Muramatsu, M; Tanaka, M | 1 |
| Amano, T; Fukuuchi, Y; Gotoh, F; Kawamura, J; Kobari, M; Obara, K; Suzuki, N; Tanaka, K; Uematsu, D | 1 |
| Aihara, H; Kaneko, K; Tsuchida, K; Yamazaki, R | 1 |
| Satoh, H; Tsuchida, K | 1 |
| Miyajima, E; Miyata, N; Otomo, S; Tsuchida, K; Yamaura, H | 1 |
| Fukushima, K; Mizuno, K; Ogawa, N; Satoh, T; Suwa, T | 1 |
| Hatayama, K; Nakazato, A; Ogawa, T; Tsuchida, K | 1 |
22 other study(ies) available for cd 349 and dihydropyridines
| Article | Year |
|---|---|
Serotonin-induced vasoconstriction in dog kidney.
Topics: Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Gallic Acid; Indoles; Ketanserin; Kidney; Male; Methysergide; Renal Artery; Renal Circulation; Serotonin; Serotonin Antagonists; Tropisetron; Vasoconstriction | 1992 |
Effects of CD-349 and 8-BrcGMP on isoproterenol-induced relaxation in rabbit aorta precontracted with endothelin-1.
Topics: Animals; Aorta; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dihydropyridines; Drug Synergism; Endothelins; Isoproterenol; Male; Rabbits; Vasoconstriction; Vasodilation | 1992 |
Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Gallic Acid; Heart Rate; Male; Renal Circulation; Vasoconstriction; Vasopressins | 1990 |
Protein kinase C-mediated contraction in rabbit aorta is inhibited by CD-349, a dihydropyridine derivative.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Calcium Channel Blockers; Cyclic AMP; Dihydropyridines; Endothelins; Male; Muscle Contraction; Nitroglycerin; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rabbits | 1991 |
Electrophysiological effects of CD-349, a dihydropyridine-type calcium antagonist, on goat cardiac Purkinje fibers.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Dihydropyridines; Electrophysiology; Goats; In Vitro Techniques; Microelectrodes; Nifedipine; Nitrendipine; Purkinje Fibers | 1991 |
Effects of CD-349, a dihydropyridine derivative, on contraction induced by vasoactive agents in canine basilar artery after subarachnoid hemorrhage.
Topics: Animals; Basilar Artery; Calcium; Dihydropyridines; Dogs; Endothelium, Vascular; In Vitro Techniques; Male; Methylene Blue; Nicardipine; Potassium; Serotonin; Subarachnoid Hemorrhage; Tetradecanoylphorbol Acetate; Vasoconstriction | 1991 |
Changes in responsiveness of the canine basilar artery to endothelin-1 after subarachnoid hemorrhage.
Topics: Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Dihydropyridines; Dogs; Endothelins; In Vitro Techniques; Male; Muscle Contraction; Nicardipine; Subarachnoid Hemorrhage; Tetradecanoylphorbol Acetate | 1991 |
Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Binding Sites; Calcium Channel Blockers; Calmodulin; Dihydropyridines; Drug Interactions; Enzyme Activation | 1990 |
Mechanisms of inhibitory effects of CD-349 and K(+)-channel activators on noradrenaline-induced contraction and changes in levels of cyclic GMP in rat aorta.
Topics: Animals; Aorta, Thoracic; Benzopyrans; Calcium Channel Agonists; Calcium Channel Blockers; Cromakalim; Cyclic GMP; Dihydropyridines; Glyburide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Channels; Pyrroles; Rats; Rats, Inbred Strains | 1990 |
Effects of 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation and metabolism in cats.
Topics: Animals; Blood Pressure; Brain Chemistry; Calcium Channel Blockers; Carbon Dioxide; Cats; Cerebrovascular Circulation; Dihydropyridines; Oxygen Consumption; Time Factors | 1989 |
Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Calcium; Calcium Channel Blockers; Cattle; Cyclic GMP; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Ferricyanides; In Vitro Techniques; Nitroprusside; Pulmonary Artery; Pulmonary Veins | 1989 |
Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1989 |
Uptake of CD-349 and nitrendipine into bovine intrapulmonary artery and vein.
Topics: 2,4-Dinitrophenol; Animals; Cattle; Dihydropyridines; Dinitrophenols; In Vitro Techniques; Kinetics; Muscle, Smooth, Vascular; Nitrendipine; Pulmonary Artery; Pulmonary Veins; Temperature; Uncoupling Agents | 1989 |
Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta; Brain; Calcium Channel Blockers; Cyclic Nucleotide Phosphodiesterases, Type 1; Dihydropyridines; Enzyme Activation; In Vitro Techniques; Kinetics; Nicardipine; Nimodipine; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Rabbits | 1987 |
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by CD-349, a novel 1,4-dihydropyridine derivative: effect of EGTA on the inhibitory activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Dihydropyridines; Egtazic Acid; Female; Heart; Male; Muscle, Smooth, Vascular; Swine; Trifluoperazine | 1987 |
A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery.
Topics: Animals; Brain; Calcium Channel Blockers; Calcium Channels; Coronary Vessels; Dihydropyridines; In Vitro Techniques; Kinetics; Male; Myocardium; Radioligand Assay; Rats; Rats, Inbred Strains; Swine | 1988 |
Effects of the new calcium antagonist 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in cats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cats; Cerebrovascular Circulation; Dihydropyridines; Female; Male; Muscle, Smooth, Vascular; Vasodilation | 1988 |
Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
Topics: Animals; Basilar Artery; Calcium Channel Blockers; Cerebrovascular Circulation; Dihydropyridines; Dinoprost; Dogs; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nimodipine; Potassium Chloride; Prostaglandins F; Serotonin | 1987 |
Comparison of a calcium antagonist, CD-349, with nifedipine, diltiazem, and verapamil in rabbit spontaneously beating sinoatrial node cells.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Cell Membrane; Dihydropyridines; Diltiazem; Electrophysiology; Female; In Vitro Techniques; Male; Microelectrodes; Nifedipine; Rabbits; Sinoatrial Node; Verapamil | 1993 |
Role of cyclic GMP in inhibitory effects of CD-349 in isolated blood vessels.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium; Rabbits | 1994 |
Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog.
Topics: Animals; Bile; Biliary Tract; Calcium Channel Blockers; Carbon Radioisotopes; Dihydropyridines; Dogs; Male; Mass Spectrometry; Rats; Rats, Wistar | 1993 |
Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
Topics: Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Dihydropyridines; Dogs; Female; Heart Rate; Magnetic Resonance Spectroscopy; Male; Spectrophotometry, Infrared; Structure-Activity Relationship | 1993 |